Enfusion, Inc. (ENFN)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous Close | 11.89 |
| Open | 11.98 |
| Bid | 0.00 x 1000 |
| Ask | 0.00 x 900 |
| Day's Range | 11.85 - 12.31 |
| 52 Week Range | 7.80 - 18.35 |
| Volume | |
| Avg. Volume | 340,323 |
| Market Cap | 829.213M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.05 |
| Earnings Date | Nov 10, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.90 |
- Simply Wall St.
We Think Enfusion (NYSE:ENFN) Can Easily Afford To Drive Business Growth
We can readily understand why investors are attracted to unprofitable companies. For example, although...
- Business Wire
Enfusion Names Michael Spellacy as Board Chair and Non-Executive Director
NEW YORK & LONDON & HONG KONG, January 11, 2023--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-native software-as-a-service (SaaS) solutions for investment managers, today announced that on January 9, 2023, its Board of Directors (the "Board") had appointed Michael Spellacy, as Board Chair, effective immediately.
- Simply Wall St.
Enfusion (NYSE:ENFN) shareholders have endured a 55% loss from investing in the stock a year ago
Taking the occasional loss comes part and parcel with investing on the stock market. Unfortunately, shareholders of...
© 2023 Yahoo. All rights reserved.
